NCT05485038
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Not yet recruiting
Not Applicable
Drug Category: Other
Key Eligibility Criteria:
Gender: All
Age: 18 Years to 69 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes:
Exclusions: Patients with prior radiation therapy to the brain
https://ClinicalTrials.gov/show/NCT05485038